Nizatidine
CAS No. 76963-41-2
Nizatidine( LY139037 )
Catalog No. M15911 CAS No. 76963-41-2
Nizatidine is a histamine H2 receptor antagonist with low toxicity that inhibits gastric acid secretion.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | 37 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 49 | In Stock |
|
Biological Information
-
Product NameNizatidine
-
NoteResearch use only, not for human use.
-
Brief DescriptionNizatidine is a histamine H2 receptor antagonist with low toxicity that inhibits gastric acid secretion.
-
DescriptionNizatidine is a histamine H2 receptor antagonist with low toxicity that inhibits gastric acid secretion.(In Vivo):Nizatidine (oral gavage; 27 mg/kg; once daily; at 12 weeks of age and were sacrificed at 30 weeks after development of HCC in the setting of nonalcoholic steatohepatitis (NASH)) results in a 35% reduction of tumor nodules relative to controls. Nizatidine results in a 60% reduction in tumor nodules, reduces collagen proportional area and expression of profibrotic markers in DEN-injured rats.Nizatidine (oral gavage; 27 mg/kg; once daily; 4 weeks) decreases the incidence of gastric ulceration, and significantly decreases the mean ulcer score and ulcer index in male albino rats.
-
In Vitro——
-
In VivoNizatidine (oral gavage; 27 mg/kg; once daily; at 12 weeks of age and were sacrificed at 30 weeks after development of HCC in the setting of nonalcoholic steatohepatitis (NASH)) results in a 35% reduction of tumor nodules relative to controls. Nizatidine results in a 60% reduction in tumor nodules, reduces collagen proportional area and expression of profibrotic markers in?DEN-injured rats.Nizatidine (oral gavage; 27 mg/kg; once daily; 4 weeks) decreases the incidence of gastric ulceration, and significantly decreases the mean ulcer score and ulcer index in male albino rats. Animal Model:Male albino ratsDosage:27 mg/kgAdministration:Oral gavage; 27 mg/kg; once daily; 4 weeks Result:Was effective in the management of NSAIDs induced peptic ulcer in rats.
-
SynonymsLY139037
-
PathwayEndocrinology/Hormones
-
TargetAChR
-
RecptorAChE| H2 receptor
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number76963-41-2
-
Formula Weight331.46
-
Molecular FormulaC12H21N5O2S2
-
Purity>98% (HPLC)
-
SolubilityEthanol: 18 mg/mL (54.3 mM); Water: 28 mg/mL (84.47 mM); DMSO: 66 mg/mL (199.11 mM)
-
SMILESCN/C(NCCSCC1=CSC(CN(C)C)=N1)=C\[N+]([O-])=O
-
Chemical Name(E)-N-(2-(((2-((dimethylamino)methyl)thiazol-4-yl)methyl)thio)ethyl)-N-methyl-2-nitroethene-1,1-diamine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lin TM, et al. J Pharmacol Exp Ther, 1986, 239(2), 406-410.
molnova catalog
related products
-
Syn-Ake acetate
Syn-Ake acetate is a muscarinic acetylcholine receptor antagonist.
-
Pirimiphos-methyl
Pirimiphos-methyl is a rapid-acting organophosphorus insecticide and acaricide, causing inhibition of AChE in target organisms.
-
Nicotine
Nicotine is the primary pharmacologic component of tobacco. It acts on nicotinic acetylcholine receptors (nAChRs) in the peripheral nervous system (autonomic ganglia and adrenal medulla neuromuscular junction) and the central nervous system (CNS).
Cart
sales@molnova.com